The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcomaMarilyn Heng, Akihiko Matsumine, Jay S. Wunder et al.|European Journal of Cancer|2019Cited by 79
Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma†Akira Kawai, Kazuo Isu, Toshifumi Ozaki et al.|Japanese Journal of Clinical Oncology|2016Cited by 67
A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroupAkira Kawai, Nobuaki Fukasawa, Toshifumi Ozaki et al.|Japanese Journal of Clinical Oncology|2016Cited by 38
Multicenter Phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcomaHideshi Sugiura, Hideo Mugishima, Takeshi Ishii et al.|Journal of Orthopaedic Science|2010Cited by 26